The Aluminum Firestorm Starts Tomorrow
How we got to this point, that we never "nailed" this question of aluminum safety, and were "saved" by a Danish epidemiologist who had a last-minute "hunch," is a subject of a future story. But, as a top vaccine expert told me, "one study will not be enough."
At today's ACIP meeting, the HBV vaccine was discussed, which contains aluminum. In response to a question about safety, an ACIP member, Dr Evelyn Griffin, jumped in to say, "Sometimes autoimmune conditions take decades to develop... One specific example. Researcher Romain Gherardi, to give something more concrete. Macrophagic Myofasciitis (MMF). He and his researchers sampled injection sites, granulomas, called MMF lesions, where they were able to identify aluminum in those granulomas... These patients had autoimmune conditions, brain fog, generalized weakness, to the degree of debilitating disease, where they were unable to work, function in their daily activities. These conditions are characterized in close association with the vaccine..."
Who is Evelyn Griffin? More on her below. And what about MMF?
As we previously reported, Macrophagic myofasciitis (MMF) is a syndrome discovered by Gherardi in a saga he describes in his 2016 book, “Toxic Story: Two or Three Embarrassing Truths About Vaccine Adjuvants.”
According to Gherardi, MMF is an exceedingly rare condition with vague symptoms that can develop in adults years after receiving an aluminum-containing vaccine. And Gherardi showed that if you biopsy their deltoid - the shoulder muscle where the vaccine was injected years earlier - you do find traces of aluminum.
There is only one problem. He never biopsied people without symptoms. His excuse is that this would be unethical. He is clearly wrong. Even sham surgeries have been done in the interest of research. The real reason he did not biopsy healthy individuals is clear: they, too, would likely have traces of aluminum at the site of vaccination. It’s what we call in medicine a “red herring” - a totally irrelevant finding.
Of course, this is not to diminish in any way the symptoms and the suffering of the patients. Gherardi’s research, his book and his activism led to the patients in France forming their own association called E3M. Its website says that the group “does not oppose vaccination in principle, but advocates for the use of aluminum-free vaccines.” In 2013, when the French Ministry of Health refused to fund Gherardi’s work, E3M members went on a hunger strike until the Ministry relented. When I spoke to Crepeaux, Gherardi’s former student and a recent guest on CHD TV, she denied that Gherardi was involved in organizing the strike. But regardless, as a physician, I am not sure that these patients are helped by tying their symptoms to a vaccine they received years earlier.
ACIP Day 2 tomorrow: aluminum in the cross-hairs
